Korro Bio is trading 7.6% up at $10.78 in September 21 pre-market trading, apparently reflecting improved broader market risk appetite.
- It closed at $10.02 on September 18, 2026.
- U.S. futures and global equities were broadly higher, while the stock recovered following two sharply lower sessions.
- No confirmed company-specific announcement explains the rebound; the latest official investor-relations release remains the September 11 inducement-grant disclosure. Confidence is low because no direct catalyst or volume data was identified.